New Targets in Non–Small Cell Lung Cancer | Oncohema Key
Recent Advances in Targeting ROS1 in Lung Cancer - ScienceDirect
Targeting ROS1 with Anaplastic Lymphoma Kinase Inhibitors: A Promising Therapeutic Strategy for a Newly Defined Molecular Subset of Non–Small-Cell Lung Cancer - ScienceDirect
Agents Targeting ROS1 Gain Traction in NSCLC
Cancers | Free Full-Text | Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies
ROS1: ROS Proto-oncogene 1
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer | NEJM
More Choices to Treat Lung Cancer | Cancer Today
Caveolin-1 Regulates Endothelial Adhesion of Lung Cancer Cells via Reactive Oxygen Species-Dependent Mechanism | PLOS ONE
ROS in cancer therapy: the bright side of the moon | Experimental & Molecular Medicine
ROS1-dependent cancers — biology, diagnostics and therapeutics | Nature Reviews Clinical Oncology
ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy - The Lancet Respiratory Medicine
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma - ScienceDirect
ROS1 Mutation in Lung Cancer - What is ROS1 Mutation in Lung Cancer?
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial - The Lancet Oncology
Cancers | Free Full-Text | N′1,N′3-Dimethyl-N′1,N′3-bis(phenylcarbonothioyl) Propanedihydrazide (Elesclomol) Selectively Kills Cisplatin Resistant Lung Cancer Cells through Reactive Oxygen Species (ROS)
Resveratrol Induces Premature Senescence in Lung Cancer Cells via ROS-Mediated DNA Damage | PLOS ONE
Recent Advances in Targeting ROS1 in Lung Cancer - ScienceDirect
![PDF] Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1833bc15a861f5f020a9b9b360aab6055f53bdd6/2-Figure1-1.png "PDF] Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer | Semantic Scholar")
PDF] Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer | Semantic Scholar
Frontiers | Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling
ROS1-dependent cancers — biology, diagnostics and therapeutics | Nature Reviews Clinical Oncology
Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies - RSC Advances (RSC Publishing)
